Guafensin Fibromyalgia | List of High Impact Articles | PPts | Journals | Videos

Fibromyalgia: Open Access
Open Access

Guafensin Fibromyalgia

Search results for
Guafensin Fibromyalgia

Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

Guafensin Fibromyalgia

Guafensin is an expectorant. If it is related to the physical body then guafensin will have no results. It has not been approved by the FDA for the treatment of fibromyalgia. The protocol involves three parts initially titrating the guafesin, avoiding salicylates and a low carbohydrate diet. It has been claimed that guaifenesin increases the excretion of uric acid and possibly to increase phosphate excretion.

Related journals of Guafensin Fibromyalgia

Fibromyalgia: Open Access, International Journal of Physical Medicine & Rehabilitation, Rheumatology: Current Research, Journal of Sports Medicine & Doping Studies, Journal of Yoga & Physical Therapy, Myalgia And Myositis, Skeletal Muscle Journal, Sarcopenia and Muscle, Muscle & nerve.

Guafensin Fibromyalgia

Speaker PPTs

High Impact List of Articles
Conference Proceedings